220 related articles for article (PubMed ID: 29044109)
1. APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.
Bohn JA; Thummar K; York A; Raymond A; Brown WC; Bieniasz PD; Hatziioannou T; Smith JL
Nat Commun; 2017 Oct; 8(1):1021. PubMed ID: 29044109
[TBL] [Abstract][Full Text] [Related]
2. Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.
Bohn JA; DaSilva J; Kharytonchyk S; Mercedes M; Vosters J; Telesnitsky A; Hatziioannou T; Smith JL
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578294
[TBL] [Abstract][Full Text] [Related]
3. Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function.
Jang GM; Annan Sudarsan AK; Shayeganmehr A; Prando Munhoz E; Lao R; Gaba A; Granadillo Rodríguez M; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
Mol Cell Proteomics; 2024 May; 23(5):100755. PubMed ID: 38548018
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA.
Matsuoka T; Nagae T; Ode H; Awazu H; Kurosawa T; Hamano A; Matsuoka K; Hachiya A; Imahashi M; Yokomaku Y; Watanabe N; Iwatani Y
Nucleic Acids Res; 2018 Nov; 46(19):10368-10379. PubMed ID: 30060196
[TBL] [Abstract][Full Text] [Related]
5. The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.
Shaban NM; Shi K; Lauer KV; Carpenter MA; Richards CM; Salamango D; Wang J; Lopresti MW; Banerjee S; Levin-Klein R; Brown WL; Aihara H; Harris RS
Mol Cell; 2018 Jan; 69(1):75-86.e9. PubMed ID: 29290613
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Loss of APOBEC3H Activity during Primate Evolution.
Garcia EI; Emerman M
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925657
[TBL] [Abstract][Full Text] [Related]
7. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
Binka M; Ooms M; Steward M; Simon V
J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
[TBL] [Abstract][Full Text] [Related]
8. Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.
Kanagaraj A; Sakamoto N; Que L; Li Y; Mohiuddin M; Koura M; Wakae K; Kurachi M; Muramatsu M; Kitamura K
Biochem Biophys Res Commun; 2019 Oct; 518(1):26-31. PubMed ID: 31400856
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity.
Li MM; Emerman M
J Virol; 2011 Aug; 85(16):8197-207. PubMed ID: 21653666
[TBL] [Abstract][Full Text] [Related]
10. Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H.
Köck J; Blum HE
J Gen Virol; 2008 May; 89(Pt 5):1184-1191. PubMed ID: 18420796
[TBL] [Abstract][Full Text] [Related]
11. The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.
Ooms M; Majdak S; Seibert CW; Harari A; Simon V
J Virol; 2010 Aug; 84(16):7961-9. PubMed ID: 20519396
[TBL] [Abstract][Full Text] [Related]
12. The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H.
Wang J; Becker JT; Shi K; Lauer KV; Salamango DJ; Aihara H; Shaban NM; Harris RS
J Mol Biol; 2019 Dec; 431(24):5019-5031. PubMed ID: 31628948
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
Kouno T; Silvas TV; Hilbert BJ; Shandilya SMD; Bohn MF; Kelch BA; Royer WE; Somasundaran M; Kurt Yilmaz N; Matsuo H; Schiffer CA
Nat Commun; 2017 Apr; 8():15024. PubMed ID: 28452355
[TBL] [Abstract][Full Text] [Related]
14. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.
Zhen A; Du J; Zhou X; Xiong Y; Yu XF
PLoS One; 2012; 7(7):e38771. PubMed ID: 22859935
[TBL] [Abstract][Full Text] [Related]
15. Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.
Feng Y; Love RP; Ara A; Baig TT; Adolph MB; Chelico L
J Biol Chem; 2015 Nov; 290(45):27188-27203. PubMed ID: 26396192
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
17. The Structural Interface between HIV-1 Vif and Human APOBEC3H.
Ooms M; Letko M; Simon V
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031368
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.
Salamango DJ; Becker JT; McCann JL; Cheng AZ; Demir Ö; Amaro RE; Brown WL; Shaban NM; Harris RS
Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224517
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Structure, Multimerization, Subcellular Localization and mC Selectivity of a Genomic Mutator and Anti-HIV Factor APOBEC3H.
Ito F; Yang H; Xiao X; Li SX; Wolfe A; Zirkle B; Arutiunian V; Chen XS
Sci Rep; 2018 Feb; 8(1):3763. PubMed ID: 29491387
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.
Harari A; Ooms M; Mulder LC; Simon V
J Virol; 2009 Jan; 83(1):295-303. PubMed ID: 18945781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]